Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses productivity. Key pointsThe last 20 years have seen a slump in productivity growth in Australia from over 2% pa to less than 1% pa. This has curtailed growth in living standards and real wages. It will adversely affect asset class returns if […]
Why the need to lift productivity and why it might be hard Read More »
15 Aug 2023 – The S&P/ASX 200 index is currently trading 0.53 per cent higher at 7,315.80. Wages have seen a 0.8 per cent increase, falling short of the anticipated 0.9 per cent growth.
Afternoon update: ASX 0.53% higher, China unexpectedly cuts rates Read More »
The S&P/ASX 200 index is currently trading 0.53 per cent higher at 7,315.80. Wages have seen a 0.8 per cent increase, falling short of the anticipated 0.9 per cent growth, resulting in an annual wage growth of 3.6 per cent. This is below the projected 3.7 per cent and a decline from the 3.7 per
Afternoon update: ASX 0.53% higher, China unexpectedly cuts rates Read More »
The Australian dollar experienced a decrease in value following the release of second quarter wages data that fell short of expectations. This development strengthens the argument for the Reserve Bank of Australia to maintain current interest rates without making any adjustments. The Australian dollar was trading at 64.7 US cents, down from around 64.9 cents
ASX up 0.63% at noon as wage growth comes in lower than expected Read More »
15 Aug 2023 – A snapshot of the stocks on the move, featuring Lake Resources (ASX:LKE), Chimeric Therapeutics (ASX:CHM) and Sunstone Metals (ASX:STM).
Stocks of the Hour: Lake Resources, Chimeric Therapeutics, Sunstone Metals Read More »
Lake Resources (ASX:LKE) completes an intermediate milestone to achieve DFS with successful extraction and injection tests at its flagship Kachi Project. In response, Lake CEO David Dickson said, “The tests represent a significant milestone for the Project, as they provide important data and higher confidence for our modelling, which is essential for the completion of
Stocks of the Hour: Lake Resources, Chimeric Therapeutics, Sunstone Metals Read More »
Shareholders of the blood products giant CSL (ASX:ASX) are set to benefit as the company increased its revenue and earnings in the year leading up to June 30. On Tuesday, the company unveiled that it had raised its full-year underlying profit by 10%, reaching $2.61 billion USD ($4 billion AUD), attributed to higher sales in
Shareholders to receive more from CSL as revenue and earnings surge Read More »
Temple & Webster (ASX:TPW), a standout during the pandemic’s online retailing surge, is now on the path to recovery after facing difficulties for most of the 2022-23 financial year. In the year leading up to June, revenue experienced a 7.2% decline, dropping from $426.3 million in the pandemic-fueled year of 2021-22 to $395.5 million. Consequently,
Temple & Webster’s steady rebound following a challenging year Read More »
Hearing device manufacturer, Cochlear (ASX:COH), is poised for a strong performance in the fiscal year 2023-24, following a commendable performance until June. The company predicts underlying net earnings within the range of $355 to $375 million for this fiscal year. Should this projection materialise, it would signify a 16% to 23% enhancement compared to the
Cochlear anticipates robust performance for 2023-24 Read More »
Treasury Wine Estates (ASX:TWE) is aiming for a stronger performance in 2024, as the year leading up to June 30 proved to be less dire than initially anticipated. Benefiting from its luxury Penfolds division, TWE managed to weather the challenging landscape of 2022-23, positioning itself for a more promising year. The company is reinvigorating its
Treasury Wine Estates anticipates improved performance in 2024 Read More »
